Alnylam Pharmaceuticals
ALNY
#563
Rank
A$59.42 B
Marketcap
A$448.10
Share price
-0.47%
Change (1 day)
16.96%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company